New version of India 20 Iressa 16 sales and purchase 13621079375 price description

Product Detailed Description
bdd dd dd dh d= _dd dd dd dh d=m_h hd zd d=m
<=m_ zd =_=d/ .r/mmbr///> .r/mmbr ///>
Manager Wang, his website was recently named and exposed by the State Food and Drug Administration for illegally publishing false drug information and selling drugs. One of the websites was selling and promoting an anti-cancer drug purchased from India. Ressa. According to the reporter's investigation, many anti-cancer drugs with good efficacy, including Iressa, are expensive because of the high price of officially imported drugs, which provides space for overseas purchasing.
In recent years, a large amount of overseas drug purchasing information has emerged in the chaotic online sales market, and it is difficult to distinguish the authenticity from the fake. Experts remind that every aspect of treatment for cancer patients is very critical. They have to race against the ever-changing cancer cells and there is no room for sloppiness. If they buy counterfeit drugs, the price they will pay is their lives. Therefore, I would like to remind you that purchasing drugs overseas online is risky. If you are not careful, you may end up in a dangerous situation.
Market: The lowest price of purchasing drugs attracts patients
The reporter learned that not only Iressa, there are also overseas purchasing websites and websites for cancer drugs such as Gleevec, Tarceva, and Herceptin on the Internet. store and transfer information. These drugs are currently not produced in China and are completely imported from pharmaceutical companies in Europe and the United States. However, these drugs are quite expensive in the domestic market.
Gleevec is a patented drug from Novartis of Switzerland. It is used to treat chronic myelogenous leukemia and gastrointestinal stromal tumors. It is currently the best drug for treating leukemia in the world. It costs about 1 yuan per box and the average patient needs it per month. Tarceva costs about RMB 10,000 per box. It is currently the latest oral targeted therapy drug for non-small cell lung cancer. Clinical studies have confirmed that it is the only targeted therapy drug that can significantly prolong the survival of lung cancer patients. Herceptin is used to treat advanced stages of lung cancer. The effect on breast cancer is remarkable, and the price is about one yuan.
My father took Iressa and spent more than 100,000 yuan in half a year. He really couldn’t afford it. We all know that Herceptin is effective in treating advanced breast cancer, but the high self-pay price makes it unbearable for me. Do we just have to wait to die? Such helpless complaints can be seen everywhere on the Internet. Accompanying this is drug purchasing information. On a website called XinTong, information about the supply of Peruvian Tarceva appeared, with a price tag for a box of Yuanyuanxin Pharmaceuticals, which specializes in selling imported drugs online. It claims to be a professional purchasing agent for Herceptin from the United States, m Price: Yuan/branch. There is also the Indian Desen Purchasing Online, which has been exposed and shut down by the State Food and Drug Administration. It has long been selling Iressa purchasing price: yuan direct mail information from India.
Expert: Strong generic drugs have low cost and low price
Why is there such a big price difference between the Indian version of anti-cancer drugs and the original imported drugs sold in China? Luo Rongcheng, vice president of Nanfang Hospital, explained that the main reason is patent issues. The research and development of an anti-tumor drug requires a large initial investment and requires rigorous clinical research, plus tariffs. Therefore, the price of the drug cannot be reduced, and these drugs are also protected by patent rights. However, if a public health incident like SARS occurs, special measures can be taken. In 2018, the General Council of the World Trade Organization passed the "Implementation Resolution on Paragraph 6 of the Doha Declaration", which clarified that developing member states and least developed member states may implement a compulsory licensing system without the consent of the patent owner when a public health crisis occurs. , sale and use of patented medicines. my country's newly implemented "Compulsory Licensing Measures for Patent Exploitation" also stipulates that in the event of a national emergency or extraordinary situation, the relevant competent authorities under the State Council may recommend that the State Intellectual Property Office grant a compulsory license to the units designated by it that meet the conditions for implementation.
Yu Mingde, president of the China Pharmaceutical Enterprise Management Association, believes that cancer does not meet the conditions for forced imitation due to its limited scope and harm. But India is exactly the exception. India is a major country in the world of generic drugs. Its current Patent Law clarifies the product patent of the drug itself, but stipulates that if it is unable to obtain, afford or cannot provide it appropriately, local companies can apply to the Intellectual Property Office of India. Under compulsory licensing, domestic companies that obtain the compulsory license can produce and sell imitation products, but they should pay royalties to the company holding the patent. Because of this, anti-cancer drugs have appeared in India that are much cheaper than in China.
Efficacy: The Indian version of anti-cancer drugs cannot guarantee the efficacy
The biggest problem for patients with the Indian version of anti-cancer drugs is whether the efficacy is guaranteed. Zhi Xiuyi, director of the Lung Cancer Center of Capital Medical University, expressed concern about the quality of the cheap generic version of Iressa. In our clinical work, we discovered early on that there was an Indian version of Iressa. He encountered some patients who were I hid it from the doctor and used the so-called cheaper Iressa from the underworld. Zhi Xiuyi said that there were patients who originally took the regular Iressa but switched to the Indian version due to financial reasons. In the end, their condition worsened and they came to see a doctor. Some doctors also expressed objections. Luo Rongcheng said cautiously: Without a large-sample comparative survey, I cannot draw a conclusion on the efficacy of the so-called Indian version of Iressa rq, or the Indian version of other cancer drugs. It is not clear. Many doctors in the pharmacy department have no idea about this. It is legal for patients to bring drugs from abroad to China for self-administration. However, because we cannot master the clinical trial data of these drugs, we do not know the efficacy of these drugs at all and cannot control their use. Therefore, when seeking treatment, we advise patients to stop these drugs and the hospital will refill them.
The main concern is that patients will buy counterfeit Iressa. Luo Rongcheng said, as far as I know, there are domestic manufacturers that specialize in making counterfeit patented drugs. This is absolutely dangerous. Once a patient takes it, it will affect regular treatment, delay the condition, and even worsen the condition. . Zhi Xiuyi also pointed out that a considerable number of illegal people are engaged in selling the Indian version of Iressa. I really don’t know if there will be a Cambodian or Vietnamese version one day. He expressed obvious concern about the low-priced Iressa appearing through informal channels. Worry. In addition, Zhi Xiuyi also said that the current domestic genuine Iressa is priced by relevant national departments. With its widespread clinical use, the price will definitely drop to a certain extent. As an individual, Zhi Xiuyi does not want patients to take it. After the genuine drugs showed good effects, they were changed to so-called low-priced versions due to economic factors.
Food and Drug Administration: Unapproved imported drugs are counterfeit
The State Food and Drug Administration pointed out that according to the laws of our country, all smuggled drugs that have not been formally registered and marketed in our country are considered counterfeit drugs. Luo Rongcheng said that when patients purchase medicines through informal channels, if something goes wrong, it is difficult for them to have laws to protect their rights. The cost of defending rights overseas will be very high. Moreover, the doctor who is the patient’s attending doctor is not legally responsible because It is the result of patients purchasing their own medicines. Therefore, patients are reminded to be cautious when purchasing overseas.
In addition, the head of publicity for AstraZeneca Pharmaceutical Co., Ltd. China told reporters: There are two possibilities for Indian Iressa flowing into the country: one is an Indian generic drug, and the other is a fake drug with no origin. . However, according to relevant national regulations, even if Iressa is officially produced in India, it has not undergone clinical verification and any quality inspection in China, and has not obtained import approval from the State Food and Drug Administration. It has flowed into China through illegal channels and is considered a fake drug.